TY - JOUR
T1 - Theophylline therapy for cheyne-stokes respiration during sleep in a 41-year-old man with refractory arterial hypertension
AU - Wolf, Jacek
AU - Świerblewska, Ewa
AU - Jasiel-Wojculewicz, Hanna
AU - Gockowski, Krzysztof
AU - Wyrzykowski, Bogdan
AU - Somers, Virend K.
AU - Narkiewicz, Krzysztof
N1 - Funding Information:
Financial/nonfinancial disclosures: The authors have reported to CHEST the following conflicts of interest: Drs Wolf and Narkiewicz have received lectures fees from ResMed. Dr Somers has served as a consultant for Neu Pro; Respicardia, Inc; Sorin Inc; Price Waterhouse; and ResMed and has received grant support from Philips-Respironics Foundation. Mayo Foundation has received a gift from the Philips-Respironics Foundation for the study of sleep apnea and cardiovascular disease.
PY - 2014/7
Y1 - 2014/7
N2 - We report a case of a 41-year-old man who was noted to have position-dependent Cheyne-Stokes respiration with central sleep apnea (CSA) during sleep. The patient had multiple cardiovascular risk factors and target organ damages, including a history of two myocardial infarctions, transient ischemic attack, and chronic kidney disease. His hypertension was refractory to a number of antihypertensive medicines, however, a complete elimination of sleep-disordered breathing with oral theophylline treatment was paralleled by a signifi cant BP fall with a subsequent need for reduction of antihypertensive drugs. Following these surprising observations we decided to withdraw theophylline from treatment (in-clinic). Theophylline discontinuation resulted in a gradual increase in BP and an urgent call for antihypertensive treatment modifi cation. These observations suggest a potent hypotensive action of oral theophylline via Cheyne- Stokes respiration with CSA elimination. Our data suggest that CSA may be a mechanism that raises BP even during the daytime.
AB - We report a case of a 41-year-old man who was noted to have position-dependent Cheyne-Stokes respiration with central sleep apnea (CSA) during sleep. The patient had multiple cardiovascular risk factors and target organ damages, including a history of two myocardial infarctions, transient ischemic attack, and chronic kidney disease. His hypertension was refractory to a number of antihypertensive medicines, however, a complete elimination of sleep-disordered breathing with oral theophylline treatment was paralleled by a signifi cant BP fall with a subsequent need for reduction of antihypertensive drugs. Following these surprising observations we decided to withdraw theophylline from treatment (in-clinic). Theophylline discontinuation resulted in a gradual increase in BP and an urgent call for antihypertensive treatment modifi cation. These observations suggest a potent hypotensive action of oral theophylline via Cheyne- Stokes respiration with CSA elimination. Our data suggest that CSA may be a mechanism that raises BP even during the daytime.
UR - http://www.scopus.com/inward/record.url?scp=84903837331&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84903837331&partnerID=8YFLogxK
U2 - 10.1378/chest.13-2897
DO - 10.1378/chest.13-2897
M3 - Article
C2 - 25010981
AN - SCOPUS:84903837331
SN - 0012-3692
VL - 146
SP - e8-e10
JO - Chest
JF - Chest
IS - 1
ER -